tovorafenib 300 MG Powder for Oral Suspension [Ojemda]
RxNorm concept 2682445, branded drug (sbd). Prescribable name: ojemda 25 MG in 1 mL Powder for Oral Suspension.
- RxCUI
- 2682445
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2682445 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ojemda 25 MG per 1 ML Powder for Oral Suspension; Ojemda 300 MG Powder for Oral Suspension; Ojemda 300 MG per 12 ML Powder for Oral Suspension
Related concepts
- tovorafenib 300 MG (SCDC, consists of)
- tovorafenib 300 MG [Ojemda] (SBDC, consists of)
- Powder for Oral Suspension (DF, has dose form)
- Ojemda (BN, has ingredient)
- tovorafenib 300 MG Powder for Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 82950001201
- 82950011210
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2682445 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2682445 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2682445. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.